Newfeed

SINGAPORE, May 12, 2024 /PRNewswire/ — SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced first preclinical data of its novel human papillomavirus (HPV)-specific T cell receptor

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: